MACRA: A Stepping-Stone for Broader Changes

Posted by Christina Corridon on Dec 11, 2017 12:00:00 PM

Howard Deutsch co-wrote this blog post with Christina Corridon.

In its current form, the Medicare Access and CHIP (Children’s Health Insurance Program) Reauthorization Act (MACRA) of 2015 directly impacts the reimbursement rates and methodology of the physician fee schedule under Medicare Part B. However, MACRA is unlikely to have a significant impact on physician behavior or drug choice. Nonetheless, MACRA is part of a larger transition of payment based on volume to payment based on value (quality and cost reduction). Physicians will be penalized for continuing with “business as usual,” and newfound attention to tracking and reporting outcomes will be rewarded.


>
Read More

ESMO 2017: Examining New Models to Define, Measure and Pay for Value

Posted by Richard Secker-Johnson on Sep 27, 2017 11:08:36 AM

Can true value-based pricing ever be a reality in Europe? If the answer is no, we may well be headed towards a price/access “crisis” as rising oncology costs continue to outstrip country healthcare budgets. If the answer is yes, it certainly seems like there’s still a long way to go.


>
Read More